Impaired SHP2-Mediated Extracellular Signal-Regulated Kinase Activation Contributes to Gefitinib Sensitivity of Lung Cancer Cells with Epidermal Factor Receptor-Activating Mutations

Impaired SHP2-Mediated Extracellular Signal-Regulated Kinase Activation Contributes to Gefitinib Sensitivity of Lung Cancer Cells with Epidermal Factor Receptor-Activating Mutations

November 1st, 2010

Bibliographic Details
Main Authors: Lazzara, Matthew J. (Contributor), Lane, Keara M. (Contributor), Chan, Richard (Author), Jasper, Paul J. (Author), Sorger, Peter K. (Author), Neel, Benjamin G. (Author), Yaffe, Michael B (Author), Jacks, Tyler E (Author), Lauffenburger, Douglas A (Author)
Other Authors: Massachusetts Institute of Technology. Department of Biological Engineering (Contributor), Massachusetts Institute of Technology. Department of Biology (Contributor), Koch Institute for Integrative Cancer Research at MIT (Contributor), Yaffe, Michael B. (Contributor), Jacks, Tyler E. (Contributor), Lauffenburger, Douglas A. (Contributor)
Format: Article
Language:English
Published: American Association for Cancer Research, 2012-10-11T17:34:10Z.
Subjects:
Article
Online Access:Get fulltext

Internet

Get fulltext

Similar Items